Xenetic Biosciences Reports Quarterly Results for June 30, 2026

What Happened

• On August 7, 2026, Xenetic Biosciences, Inc. announced results for the three months ended June 30, 2026 in a press release.
• The company furnished the full text of that press release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02).

Key Details

• Press release date: August 7, 2026.
• Reporting period: three months ended June 30, 2026.
• Filing: Form 8-K discloses the results under Item 2.02 (Results of Operations and Financial Condition) and includes Exhibit 99.1 (press release) and Exhibit 104 (Inline XBRL cover page).

Why It Matters

• The 8-K notifies investors that Xenetic has publicly released its latest quarterly results; investors should review the Exhibit 99.1 press release for the company’s reported earnings, revenue and other financial details.
• This filing is a prompt, official source of the company’s quarterly performance; further detail and audited figures may follow in subsequent periodic filings (e.g., Form 10-Q).